![Abcuro](https://www.impactnews-wire.com/wp-content/uploads/2023/12/Abcuro_logo.jpg)
Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors
December 06, 2023 07:00 AM Eastern Standard Time NEWTON, Mass.–(BUSINESS WIRE)–Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells, today announced the appointment of Mark Pruzanski, M.D., as Chairman of its Board of Directors. Dr. Pruzanski brings more than 30 years of experience as a life sciences executive, entrepreneur … Continue reading Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors